A computational multi-targeting approach for drug repositioning for psoriasis treatment
Abstract Background Psoriasis is an autoimmune inflammatory skin disease that affects 0.5–3% of the world’s population and current treatment options are posed with limitations. The reduced risk of failure in clinical trials for repositioned drug candidates and the time and cost-effectiveness has pop...
Main Authors: | Akachukwu Ibezim, Emmanuel Onah, Ebubechukwu N. Dim, Fidele Ntie-Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-021-03359-2 |
Similar Items
-
The Immunogenetics of Psoriasis and Implications for Drug Repositioning
by: Xuan Xu, et al.
Published: (2017-12-01) -
Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
by: Joonhyeok Choi, et al.
Published: (2017-12-01) -
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors
by: Joonhyeok Choi, et al.
Published: (2015-12-01) -
Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
by: Xuan-Yi Ye, et al.
Published: (2017-06-01) -
Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease
by: Xun Wang, et al.
Published: (2021-02-01)